TY - JOUR
T1 - PI3King the Environment for Growth
T2 - PI3K Activation Drives Transcriptome Changes That Support Oncogenic Growth
AU - Claridge, Sally E.
AU - Hopkins, Benjamin D.
N1 - Publisher Copyright:
© 2022 American Association for Cancer Research
PY - 2022/6/15
Y1 - 2022/6/15
N2 - PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation.
AB - PI3K signaling plays an integral role in cells, coordinating the necessary alterations in cellular metabolism and programs to support survival and proliferation. In the first genome-wide analysis of alternative splicing in PIK3CA-mutant breast cancer, Ladewig and colleagues show that activating mutations in PIK3CA alter the use of known exons and splice junctions, leading to changes in gene expression and transcription factor activity that promote an oncogenic phenotype. Their work reveals a novel mechanism underlying the functional impact of PI3K signal activation in the context of breast cancer, where PIK3CA mutations are common and PI3K inhibitors are part of the standard of care. Their studies uncover a feedforward mechanism by which PI3K signaling enables a shift in the spectrum of translated splice variants as another method through which the PI3K pathway has evolved to regulate its own activity, thereby modifying the cellular response to upstream activation based on the signaling that has come before. These findings have profound implications for understanding the evolution of the PI3K pathway and the rewiring of cells in response to prolonged or repeated signal activation.
UR - http://www.scopus.com/inward/record.url?scp=85132082635&partnerID=8YFLogxK
U2 - 10.1158/0008-5472.CAN-22-1466
DO - 10.1158/0008-5472.CAN-22-1466
M3 - Article
C2 - 35702891
AN - SCOPUS:85132082635
SN - 0008-5472
VL - 82
SP - 2216
EP - 2218
JO - Cancer Research
JF - Cancer Research
IS - 12
ER -